Radical prostatectomy versus radiotherapy in M1a and low volume M1b prostate cancer patients: an indirect comparison with the STAMPEDE trial arm H

by G. Gandaglia, A. Heidenreich, D. Pfister, S. Shariat, B. Grubmuller, G. Motterle, G. Devos, D. Robesti, F. Scalvi, G. Fallara, A. Pellegrino, C. Berghen, W. Everaerts, N. Fossati, S. Scuderi, A. Martini, P.I. Karakiewicz, F. Montorsi, S. Joniau, R. Karnes, F. Barletta, C.A. Bravi, A. Briganti
Published 2020-10-01

The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with ol...

by E. Mazzone, A. Heidenreich, G. Gandaglia, D. Pfister, S. Shariat, B. Grubmuller, N. Fossati, A. Stabile, S. Scuderi, F. Pellegrino, G. Sorce, G. Fallara, G. Rosiello, A. Martini, M. Bandini, V. Cucchiara, E. Zito, A. Pellegrino, P.I. Karakiewicz, M. Moschini, R.J. Karnes, F. Montorsi, A. Briganti
Published 2020-10-01

The impact of persistently elevated PSA levels on progression and survival of patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate cancer

by D. Cannoletta, G. Gandaglia, D. Pfister, S. Shariat, B. Grubmuller, N. Fossati, A. Stabile, S. Scuderi, F. Pellegrino, G. Sorce, G. Fallara, A. Martini, V. Cucchiara, D. Robesti, A. Rizzo, F. Scalvi, A. Gallina, E. Mazzone, P.I. Karakiewicz, R.J. Karnes, F. Montorsi, A. Briganti, A. Heidenreich
Published 2020-10-01

Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. The importance of patient st...

by C.A. Bravi, N. Fossati, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-07-01

Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. The importance of an extensive, multi-modal ap...

by C.A. Bravi, N. Fossati, G. Motterle, R.J. Karnes, D. Pfister, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-07-01

Performance characteristics of PET/CT scan in men treated with salvage lymph node dissection for recurrent prostate cancer: a per patient analysis with pathological confirmation ac...

by E. Zito, N. Fossati, G. Gandaglia, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-10-01

What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? Results from a large, multi-institution...

by C.A. Bravi, N. Fossati, R.J. Karnes, G. Motterle, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K-P. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-07-01

Persistently elevated prostate-specific antigen after salvage lymph node dissection and its impact on long-term oncological outcomes. the importance of an extensive, multi-modal ap...

by C.A. Bravi, N. Fossati, G. Gandaglia, G. Motterle, R.J. Karnes, D. Pfister, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, A. Martini, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-10-01

What is the optimal surgical template for salvage pelvic lymph node dissection in patients with pelvic lymph-node recurrent prostate cancer? results from a large, multi-institution...

by C.A. Bravi, N. Fossati, G. Gandaglia, A. Martini, R.J. Karnes, G. Motterle, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-10-01

Patterns of clinical recurrences after salvage lymph node dissection for lymph-node recurrent prostate cancer and their impact on oncological outcomes. the importance of patient st...

by A. Martini, N. Fossati, G. Gandaglia, C.A. Bravi, G. Motterle, R.J. Karnes, M. Schmautz, A. Heidenreich, A. Kretschmer, A. Buchner, C. Stief, G. Devos, S. Joniau, H. Van Poppel, D. Osmonov, K. Juenemann, B. Grubmuller, S. Shariat, A. Hiester, A. Nini, P. Albers, D. Tilki, M. Graefen, I.S. Gill, A. Mottrie, F. Montorsi, A. Briganti
Published 2020-10-01